European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live04-02 23:09

European equities traded in the US as American depositary receipts were tracking lower late Thursday morning, declining 0.69% to 1,746.31 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm Evaxion (EVAX) and oil and gas company Eni (E), which climbed 4.5% and 4.1% respectively. They were followed by petroleum refiner Equinor (EQNR) and telecommunications company Nokia (NOK), which advanced 2.8% and 2.2% respectively.

The decliners from continental Europe were led by semiconductor company Sequans Communications (SQNS) and lender Banco Santander (SAN), which dropped 6.5% and 3.5% respectively. They were followed by accommodations booking company trivago (TRVG) and medical device maker EDAP TMS (EDAP), which lost 2.4% each.

The gainers from the UK were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which soared 94%, followed by biopharmaceutical company Mereo BioPharma Group (MREO), which was up 3.1%. Oil and gas companies BP (BP) and Shell (SHEL) rose 1.9% and 1.8% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Akari Therapeutics (AKTX) and cruise line operator Carnival (CUK), which fell 7.1% and 5.3% respectively. They were followed by biotech company Trinity Biotech (TRIB) and software firm Endava (DAVA), which were down 3% and 2.5% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment